Thermo Fisher Scientific
Thermo Fisher Scientific Showcases Enhanced Accelerator Drug Development Capabilities and OpenAI Strategic Collaboration at CPHI Frankfurt 2025
Company highlights its global expertise and new and expanded capabilities to help biopharma and biotech customers solve global health challenges 27 October 2025 -- Frankfurt, Germany -- Thermo Fisher Scientific Inc., the world leader in serving science, will showcase its latest flexible solutions to help boost efficiency and scale in biopharmaceutical manufacturing at every stage...
Thermo Fisher Scientific Launches International CorEvitas Clinical Registry in Adolescent Atopic Dermatitis, a Chronic Skin Condition
30 September 2024 -- Massachusetts, US -- Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the international CorEvitas Adolescent Atopic Dermatitis (AD) Registry, designed to study novel treatments for the most common inflammatory skin condition in adolescent patients. The registry recently enrolled its first European Union patient, expanding...
Thermo Fisher Scientific Expands Clinical Research Laboratory in Kentucky
The PPD clinical research business will nearly double its laboratory footprint in northern Kentucky, add more than 250 jobs 27 June 2024 -- North Carolina, US -- The PPD clinical research business of Thermo Fisher Scientific, the world leader in serving science, today announced the expansion of its central laboratory operations in Kentucky, US, dedicated...
Thermo Fisher Scientific Expands Clinical Research Laboratory in Wisconsin
The PPD clinical research business' new laboratory will enhance services in new and emerging therapeutic areas, add 350 new jobs to region 18 June 2024 -- North Carolina, US -- The PPD clinical research business of Thermo Fisher Scientific Inc, the world leader in serving science, today unveiled a new clinical research laboratory building at...
Thermo Fisher Scientific Showcases Clinical Research Innovation at DIA Annual Meeting
PPD clinical research business leads real-world data and technology panel, receives CRO Leadership Award 17 June 2024 -- California, US -- The PPD clinical research business of Thermo Fisher Scientific, the world leader in serving science, is embracing the theme of the 60th annual Drug Information Association (DIA) annual meeting today in San Diego, California,...
Thermo Fisher Scientific Launches CorEvitas Clinical Registry in Generalised Pustular Psoriasis
8 March 2024 -- Massachusetts, US -- Thermo Fisher Scientific, the world leader in serving science, today announced the launch of a new CorEvitas syndicated clinical registry in generalised pustular psoriasis (GPP). This registry, which is open to enrolment, is CorEvitas’ 10th syndicated disease registry and addresses an unmet need for real-world evidence (RWE) related...
Thermo Fisher Scientific Expands GMP Laboratory Service Offerings with Biosafety Testing Including Mycoplasma Testing
PPD clinical research business provides lab customers a comprehensive solution to help ensure safe medicines for patients 13 February 2024 -- North Carolina, US -- The PPD clinical research business of Thermo Fisher Scientific Inc, the world leader in serving science, is adding mycoplasma and additional biosafety testing capabilities to its expanding portfolio of services...
Thermo Fisher Scientific’s PPD Clinical Research Business Selected by BARDA to Support Phase 2 Platform Clinical Trial to Treat Acute Respiratory Distress Syndrome (ARDS)
21 December 2023 -- North Carolina, US -- The PPD clinical research business of Thermo Fisher Scientific Inc, the world leader in serving science, has been selected by the Biomedical Advanced Research and Development Authority (BARDA) to implement the first BARDA-supported phase 2 platform clinical trial to investigate multiple therapeutic options for the treatment of...
Thermo Fisher Scientific Announces Launch of Innovative CorEvitas Pharmacovigilance Platform for Clinical Research Registries
20 December 2023 -- Massachusetts, US -- Thermo Fisher Scientific, the world leader in serving science, today announced the launch of CorEvidence, a proprietary cloud-based data lake platform optimising pharmacovigilance case processing and safety data management processes. The new platform enhances CorEvitas clinical research registries offered by Thermo Fisher’s PPD clinical research business. CorEvidence’s first...
Thermo Fisher Scientific and National Minority Quality Forum Collaborate to Make Clinical Research More Accessible to Historically Underserved Communities
7 September 2023 -- Massachusetts, US -- Thermo Fisher Scientific, the world leader in serving science, and the National Minority Quality Forum (NMQF), an independent not-for-profit research and education organisation, today announced a collaboration to help bring clinical research to historically underserved patient populations through NMQF’s Alliance for Representative Clinical Trials (ARC). The collaboration supports...
